ResApp Signs LOI with German Private Hospital Network for Pilot Project Brisbane, Australia, 24 April 2018 -- ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that it has signed a letter of intent (LOI) with a German private hospital network to run a pilot project to test the applicability and integration of ResAppDx, ResApp’s smartphone application for diagnosing acute respiratory disease, within a German hospital structure. The partners will work together to design and run a six-month pilot project at one or more of the network’s hospitals in Germany at no-cost to ResApp. The pilot project must be started by November 1, 2018 and ResApp will not receive revenue from the pilot. At the completion of the project ResApp has agreed to grant the network an exclusive, no-cost license to use ResAppDx in their hospitals in Germany for six months and a non-exclusive, no-cost license for an additional six months. Successful completion of the pilot may lead to the network negotiating a commercial licensing agreement for use in their hospitals. Under the LOI neither party has taken on any obligations regarding ResAppDx following the pilot project and subsequent no-cost license periods.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Signs LOI with German Private Hospital Network
Ann: ResApp Signs LOI with German Private Hospital Network, page-2
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online